 Daniel Stephenson
Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 11 | 2025 | 700 | 1.210 |
Why?
| | Ceramides | 10 | 2025 | 118 | 1.190 |
Why?
| | Sphingolipids | 11 | 2024 | 77 | 1.100 |
Why?
| | Blood Preservation | 7 | 2025 | 285 | 0.930 |
Why?
| | Hemolysis | 6 | 2025 | 206 | 0.900 |
Why?
| | Pre-Eclampsia | 2 | 2023 | 190 | 0.830 |
Why?
| | Metabolomics | 7 | 2025 | 678 | 0.700 |
Why?
| | Eicosanoids | 7 | 2024 | 62 | 0.700 |
Why?
| | Biomarkers | 6 | 2024 | 4149 | 0.630 |
Why?
| | Premature Birth | 1 | 2023 | 333 | 0.620 |
Why?
| | Erythrocyte Transfusion | 3 | 2025 | 194 | 0.600 |
Why?
| | Group IV Phospholipases A2 | 5 | 2023 | 47 | 0.570 |
Why?
| | Anemia, Sickle Cell | 4 | 2025 | 270 | 0.540 |
Why?
| | Lipids | 5 | 2024 | 672 | 0.530 |
Why?
| | Cycloserine | 2 | 2024 | 5 | 0.450 |
Why?
| | Metabolome | 4 | 2025 | 350 | 0.450 |
Why?
| | Mice, Inbred NOD | 3 | 2024 | 601 | 0.430 |
Why?
| | Blood Donors | 2 | 2025 | 105 | 0.410 |
Why?
| | Mice | 25 | 2025 | 17787 | 0.390 |
Why?
| | Neural Stem Cells | 2 | 2024 | 156 | 0.380 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2025 | 140 | 0.380 |
Why?
| | Vision Disorders | 2 | 2025 | 142 | 0.380 |
Why?
| | Oxidative Stress | 7 | 2025 | 1317 | 0.340 |
Why?
| | Autophagy | 2 | 2025 | 284 | 0.330 |
Why?
| | Tears | 3 | 2024 | 28 | 0.320 |
Why?
| | Mice, Inbred C57BL | 10 | 2025 | 5757 | 0.310 |
Why?
| | Animals | 28 | 2025 | 36940 | 0.310 |
Why?
| | Aspirin | 2 | 2023 | 387 | 0.290 |
Why?
| | Multiple Sclerosis | 2 | 2024 | 455 | 0.290 |
Why?
| | Erythrocyte Aging | 2 | 2025 | 17 | 0.290 |
Why?
| | Group VI Phospholipases A2 | 2 | 2024 | 6 | 0.290 |
Why?
| | Glycolysis | 3 | 2024 | 321 | 0.290 |
Why?
| | Sepsis | 2 | 2025 | 617 | 0.280 |
Why?
| | Retinal Degeneration | 2 | 2024 | 38 | 0.280 |
Why?
| | Sphingomyelin Phosphodiesterase | 2 | 2024 | 26 | 0.260 |
Why?
| | Meibomian Glands | 2 | 2023 | 18 | 0.260 |
Why?
| | Cellular Senescence | 2 | 2025 | 189 | 0.250 |
Why?
| | Glycocalyx | 1 | 2025 | 27 | 0.240 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 45 | 0.240 |
Why?
| | Signal Transduction | 3 | 2024 | 5079 | 0.240 |
Why?
| | Aging, Premature | 1 | 2025 | 13 | 0.240 |
Why?
| | Neuroacanthocytosis | 1 | 2025 | 5 | 0.240 |
Why?
| | Carrier Proteins | 2 | 2020 | 771 | 0.230 |
Why?
| | Placenta | 2 | 2023 | 750 | 0.230 |
Why?
| | Proteostasis | 1 | 2025 | 29 | 0.230 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 815 | 0.230 |
Why?
| | Vasoconstrictor Agents | 1 | 2025 | 139 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 32 | 0.230 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 660 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 60 | 0.220 |
Why?
| | Cachexia | 1 | 2025 | 71 | 0.220 |
Why?
| | Macrophages | 2 | 2024 | 1547 | 0.220 |
Why?
| | Pyruvate Kinase | 1 | 2024 | 29 | 0.220 |
Why?
| | Glucose Transporter Type 1 | 1 | 2024 | 50 | 0.220 |
Why?
| | Vesicular Transport Proteins | 1 | 2025 | 84 | 0.220 |
Why?
| | Oleic Acid | 1 | 2024 | 40 | 0.220 |
Why?
| | Anaplasma phagocytophilum | 1 | 2024 | 3 | 0.220 |
Why?
| | Fluid Therapy | 1 | 2025 | 147 | 0.220 |
Why?
| | Lipid Metabolism | 3 | 2024 | 518 | 0.220 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2024 | 65 | 0.220 |
Why?
| | Sphingosine | 1 | 2024 | 46 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 12 | 0.210 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.210 |
Why?
| | Carnitine | 1 | 2024 | 84 | 0.210 |
Why?
| | Uric Acid | 1 | 2025 | 163 | 0.210 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 28 | 0.210 |
Why?
| | Eye Injuries | 1 | 2024 | 45 | 0.210 |
Why?
| | Humans | 34 | 2025 | 137585 | 0.210 |
Why?
| | Tandem Mass Spectrometry | 2 | 2024 | 532 | 0.210 |
Why?
| | Calcium | 2 | 2019 | 1199 | 0.200 |
Why?
| | Insulin-Secreting Cells | 2 | 2024 | 377 | 0.200 |
Why?
| | Dry Eye Syndromes | 1 | 2024 | 54 | 0.200 |
Why?
| | Fluoxetine | 1 | 2023 | 54 | 0.200 |
Why?
| | Resuscitation | 1 | 2025 | 251 | 0.200 |
Why?
| | Arginine | 1 | 2024 | 271 | 0.200 |
Why?
| | PTEN Phosphohydrolase | 1 | 2024 | 167 | 0.200 |
Why?
| | Brain Injuries, Traumatic | 2 | 2025 | 360 | 0.200 |
Why?
| | Exercise Tolerance | 1 | 2025 | 279 | 0.200 |
Why?
| | Cholesterol | 1 | 2024 | 410 | 0.190 |
Why?
| | Mustard Gas | 1 | 2024 | 103 | 0.190 |
Why?
| | Apoptosis | 4 | 2024 | 2553 | 0.190 |
Why?
| | Glutathione | 1 | 2024 | 356 | 0.190 |
Why?
| | Lung Neoplasms | 3 | 2025 | 2526 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 257 | 0.190 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2024 | 3715 | 0.190 |
Why?
| | Mast Cells | 1 | 2023 | 147 | 0.190 |
Why?
| | Inflammation | 6 | 2024 | 2837 | 0.190 |
Why?
| | Female | 21 | 2025 | 73304 | 0.190 |
Why?
| | Light | 1 | 2024 | 381 | 0.190 |
Why?
| | Mice, Inbred BALB C | 1 | 2024 | 1272 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2023 | 204 | 0.180 |
Why?
| | Neoplasm Proteins | 1 | 2025 | 434 | 0.180 |
Why?
| | Drosophila melanogaster | 1 | 2023 | 233 | 0.180 |
Why?
| | Energy Metabolism | 2 | 2024 | 922 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2024 | 1091 | 0.180 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2024 | 900 | 0.180 |
Why?
| | Head Injuries, Closed | 1 | 2021 | 48 | 0.180 |
Why?
| | Retinal Diseases | 1 | 2022 | 91 | 0.180 |
Why?
| | Affective Symptoms | 1 | 2021 | 53 | 0.180 |
Why?
| | Adipose Tissue | 1 | 2025 | 635 | 0.170 |
Why?
| | Movement Disorders | 1 | 2021 | 58 | 0.170 |
Why?
| | Male | 21 | 2025 | 67762 | 0.170 |
Why?
| | Dietary Supplements | 1 | 2025 | 561 | 0.170 |
Why?
| | Wound Healing | 2 | 2022 | 331 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 146 | 0.170 |
Why?
| | Macrophages, Peritoneal | 1 | 2020 | 94 | 0.170 |
Why?
| | Macular Degeneration | 1 | 2022 | 164 | 0.170 |
Why?
| | Motor Activity | 1 | 2025 | 718 | 0.160 |
Why?
| | Emotions | 1 | 2025 | 548 | 0.160 |
Why?
| | Cadherins | 1 | 2021 | 206 | 0.160 |
Why?
| | Hypoxia | 2 | 2023 | 1112 | 0.160 |
Why?
| | Antirheumatic Agents | 1 | 2022 | 293 | 0.160 |
Why?
| | Altitude | 1 | 2023 | 488 | 0.150 |
Why?
| | Kidney | 2 | 2024 | 1468 | 0.150 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 927 | 0.150 |
Why?
| | Reperfusion Injury | 1 | 2021 | 279 | 0.150 |
Why?
| | Cell Death | 1 | 2020 | 374 | 0.150 |
Why?
| | Phosphatidylcholines | 1 | 2019 | 147 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1724 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 622 | 0.140 |
Why?
| | Necrosis | 1 | 2018 | 246 | 0.140 |
Why?
| | Mass Spectrometry | 2 | 2020 | 739 | 0.140 |
Why?
| | Oxygen | 1 | 2022 | 931 | 0.140 |
Why?
| | Brain Concussion | 2 | 2024 | 574 | 0.140 |
Why?
| | Neutrophils | 1 | 2023 | 1238 | 0.140 |
Why?
| | Melanoma | 1 | 2024 | 760 | 0.130 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4295 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2024 | 1991 | 0.130 |
Why?
| | Disease | 1 | 2017 | 98 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 258 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 1040 | 0.120 |
Why?
| | Brain | 2 | 2025 | 2668 | 0.120 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 847 | 0.120 |
Why?
| | Liver | 1 | 2024 | 1943 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5472 | 0.120 |
Why?
| | Aging | 1 | 2024 | 1864 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1081 | 0.110 |
Why?
| | Sphingomyelins | 2 | 2024 | 33 | 0.100 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.100 |
Why?
| | Adipocytes | 2 | 2025 | 222 | 0.100 |
Why?
| | Middle Aged | 8 | 2025 | 33479 | 0.100 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2025 | 267 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2025 | 2167 | 0.100 |
Why?
| | Mammals | 2 | 2024 | 283 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2023 | 6079 | 0.090 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 491 | 0.090 |
Why?
| | Thrombin | 2 | 2023 | 152 | 0.090 |
Why?
| | Retina | 2 | 2024 | 298 | 0.090 |
Why?
| | Adult | 8 | 2025 | 37929 | 0.090 |
Why?
| | Asthma | 1 | 2024 | 2295 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2025 | 3015 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2671 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2024 | 762 | 0.070 |
Why?
| | Sex Factors | 2 | 2025 | 2071 | 0.070 |
Why?
| | Aged | 5 | 2025 | 23961 | 0.070 |
Why?
| | Proteomics | 2 | 2025 | 1111 | 0.070 |
Why?
| | Fibroblasts | 2 | 2024 | 996 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1431 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2021 | 1353 | 0.070 |
Why?
| | Cell Movement | 2 | 2022 | 967 | 0.060 |
Why?
| | Cytokines | 2 | 2025 | 2085 | 0.060 |
Why?
| | Syndecan-1 | 1 | 2025 | 38 | 0.060 |
Why?
| | Heparitin Sulfate | 1 | 2025 | 50 | 0.060 |
Why?
| | Lipolysis | 1 | 2025 | 46 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.060 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2024 | 14 | 0.060 |
Why?
| | Erythroid Cells | 1 | 2024 | 10 | 0.060 |
Why?
| | Reticulocytes | 1 | 2024 | 18 | 0.060 |
Why?
| | Enzyme Activators | 1 | 2024 | 9 | 0.060 |
Why?
| | Erythroblasts | 1 | 2024 | 19 | 0.060 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 153 | 0.060 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.060 |
Why?
| | Hexokinase | 1 | 2024 | 19 | 0.060 |
Why?
| | Erythropoiesis | 1 | 2024 | 55 | 0.060 |
Why?
| | Simvastatin | 1 | 2024 | 61 | 0.060 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2024 | 8 | 0.060 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 14 | 0.050 |
Why?
| | Photoreceptor Cells, Vertebrate | 1 | 2024 | 26 | 0.050 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 32 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3412 | 0.050 |
Why?
| | Lysophospholipids | 1 | 2024 | 80 | 0.050 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.050 |
Why?
| | Eyelids | 1 | 2024 | 37 | 0.050 |
Why?
| | Mice, SCID | 1 | 2024 | 367 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 114 | 0.050 |
Why?
| | Isoenzymes | 1 | 2024 | 304 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2024 | 60 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2024 | 84 | 0.050 |
Why?
| | Autocrine Communication | 1 | 2023 | 41 | 0.050 |
Why?
| | Depression | 2 | 2023 | 1397 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 114 | 0.050 |
Why?
| | Cornea | 1 | 2024 | 138 | 0.050 |
Why?
| | Feedback | 1 | 2023 | 173 | 0.050 |
Why?
| | Pyruvates | 1 | 2022 | 24 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2023 | 238 | 0.050 |
Why?
| | Inosine | 1 | 2022 | 14 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 816 | 0.050 |
Why?
| | Microglia | 1 | 2025 | 251 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2024 | 810 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2025 | 380 | 0.050 |
Why?
| | Iron | 1 | 2025 | 313 | 0.050 |
Why?
| | Autophagosomes | 1 | 2022 | 19 | 0.050 |
Why?
| | Rabbits | 1 | 2024 | 794 | 0.050 |
Why?
| | Hydrogen Peroxide | 1 | 2024 | 328 | 0.050 |
Why?
| | Prospective Studies | 2 | 2025 | 7604 | 0.050 |
Why?
| | Sputum | 1 | 2024 | 311 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 58 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2022 | 62 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2023 | 433 | 0.050 |
Why?
| | Behavior, Animal | 1 | 2025 | 501 | 0.050 |
Why?
| | Immunoglobulin E | 1 | 2023 | 342 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2024 | 325 | 0.050 |
Why?
| | Phosphates | 1 | 2022 | 182 | 0.050 |
Why?
| | Lysosomes | 1 | 2022 | 141 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 2475 | 0.050 |
Why?
| | Disease Resistance | 1 | 2021 | 34 | 0.050 |
Why?
| | Blotting, Western | 1 | 2024 | 1226 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2024 | 1236 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2025 | 1060 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2021 | 117 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 409 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 225 | 0.040 |
Why?
| | Cell Survival | 1 | 2024 | 1120 | 0.040 |
Why?
| | Cisplatin | 1 | 2022 | 320 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 840 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 1993 | 0.040 |
Why?
| | Tomography, Optical Coherence | 1 | 2022 | 213 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2024 | 496 | 0.040 |
Why?
| | Hemoglobins | 1 | 2022 | 353 | 0.040 |
Why?
| | Ketones | 1 | 2020 | 49 | 0.040 |
Why?
| | Naphthalenes | 1 | 2020 | 60 | 0.040 |
Why?
| | Thromboxane B2 | 1 | 2019 | 26 | 0.040 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2019 | 43 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 422 | 0.040 |
Why?
| | Proteome | 1 | 2024 | 472 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1483 | 0.040 |
Why?
| | Tensile Strength | 1 | 2019 | 97 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2021 | 255 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 641 | 0.040 |
Why?
| | Cations, Divalent | 1 | 2019 | 52 | 0.040 |
Why?
| | Dinoprostone | 1 | 2019 | 191 | 0.040 |
Why?
| | Cytosol | 1 | 2019 | 226 | 0.040 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 14 | 0.040 |
Why?
| | Cytoplasm | 1 | 2019 | 274 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 75 | 0.040 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2018 | 39 | 0.040 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2018 | 47 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1710 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 375 | 0.040 |
Why?
| | Cell Line | 1 | 2024 | 2847 | 0.040 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 121 | 0.040 |
Why?
| | Fear | 1 | 2021 | 338 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 402 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 307 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2019 | 399 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2024 | 10811 | 0.030 |
Why?
| | Fatty Acids | 1 | 2020 | 443 | 0.030 |
Why?
| | Collagen | 1 | 2019 | 452 | 0.030 |
Why?
| | Models, Biological | 1 | 2024 | 1783 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2024 | 855 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1009 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2757 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2189 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 620 | 0.030 |
Why?
| | Diet | 1 | 2024 | 1278 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3284 | 0.030 |
Why?
| | Mitochondria | 1 | 2022 | 948 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 843 | 0.030 |
Why?
| | Cell Cycle | 1 | 2018 | 601 | 0.030 |
Why?
| | Stroke | 1 | 2024 | 1120 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1590 | 0.030 |
Why?
| | Skin | 1 | 2019 | 752 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1916 | 0.030 |
Why?
| | Time Factors | 1 | 2025 | 6828 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1759 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5742 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2224 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2024 | 7635 | 0.020 |
Why?
| | Child | 2 | 2023 | 21935 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3196 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5778 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13209 | 0.020 |
Why?
| | Adolescent | 1 | 2020 | 21513 | 0.010 |
Why?
|
|
Stephenson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|